Unlocking Madrigal’s Experience with Regulatory Challenges
Time: 9:00 am
day: Conference Day 1 AM
Details:
- Leveraging learnings from Rezdiffra’s recent approval
- Exploring how no biopsy requirement was achieved
- Unearthing how their clinical trial and endpoints were defined
